Biogen tumbles after Medicare lays out Aduhelm coverage plan
Shares of Biogen tumbled Wednesday, a day after regulators slapped strict limitations on coverage the drugmaker’s new Alzheimer’s disease treatment By TOM MURPHY AP Health Writer January 12, 2022, 9:43 … Read More
![]()

